WallStSmart

Mesa Laboratories Inc (MLAB)vsVuzix Corp Cmn Stk (VUZI)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Mesa Laboratories Inc generates 3990% more annual revenue ($249.13M vs $6.09M). MLAB leads profitability with a 2.7% profit margin vs 0.0%. MLAB earns a higher WallStSmart Score of 30/100 (F).

MLAB

Avoid

30

out of 100

Grade: F

Growth: 3.3Profit: 4.0Value: 5.7Quality: 5.5
Piotroski: 5/9Altman Z: 0.70

VUZI

Avoid

16

out of 100

Grade: F

Growth: 2.7Profit: 2.5Value: 6.7Quality: 7.0
Piotroski: 4/9Altman Z: -11.95
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

MLABUndervalued (+64.0%)

Margin of Safety

+64.0%

Fair Value

$253.18

Current Price

$104.38

$148.80 discount

UndervaluedFair: $253.18Overvalued
VUZIUndervalued (+40.5%)

Margin of Safety

+40.5%

Fair Value

$4.15

Current Price

$4.23

$0.08 discount

UndervaluedFair: $4.15Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

MLAB0 strengths · Avg: 0/10

No standout strengths identified

VUZI1 strengths · Avg: 10.0/10
Debt/EquityHealth
0.0310/10

Conservative balance sheet, low leverage

Areas to Watch

MLAB4 concerns · Avg: 3.3/10
Revenue GrowthGrowth
2.6%4/10

2.6% revenue growth

Market CapQuality
$573.99M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
3.6%3/10

ROE of 3.6% — below average capital efficiency

Profit MarginProfitability
2.7%3/10

2.7% margin — thin

VUZI4 concerns · Avg: 3.5/10
Price/BookValuation
14.1x4/10

Trading at 14.1x book value

EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$259.45M3/10

Smaller company, higher risk/reward

Profit MarginProfitability
0.0%3/10

0.0% margin — thin

Comparative Analysis Report

WallStSmart Research

Bull Case : MLAB

MLAB has a balanced fundamental profile.

Bull Case : VUZI

The strongest argument for VUZI centers on Debt/Equity.

Bear Case : MLAB

The primary concerns for MLAB are Revenue Growth, Market Cap, Return on Equity. A P/E of 85.9x leaves little room for execution misses. Thin 2.7% margins leave little buffer for downturns.

Bear Case : VUZI

The primary concerns for VUZI are Price/Book, EPS Growth, Market Cap.

Key Dynamics to Monitor

VUZI carries more volatility with a beta of 1.69 — expect wider price swings.

MLAB is growing revenue faster at 2.6% — sustainability is the question.

MLAB generates stronger free cash flow (11M), providing more financial flexibility.

Monitor SCIENTIFIC & TECHNICAL INSTRUMENTS industry trends, competitive dynamics, and regulatory changes.

Bottom Line

MLAB scores higher overall (30/100 vs 16/100). VUZI offers better value entry with a 40.5% margin of safety. Both earn "Avoid" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Mesa Laboratories Inc

TECHNOLOGY · SCIENTIFIC & TECHNICAL INSTRUMENTS · USA

Mesa Laboratories, Inc. designs, manufactures, and markets quality control instruments and disposable products in the United States, Europe, Asia, North America, and internationally. The company is headquartered in Lakewood, Colorado.

Vuzix Corp Cmn Stk

TECHNOLOGY · CONSUMER ELECTRONICS · USA

Vuzix Corporation designs, manufactures, markets and sells augmented reality (AR) computing and display devices for consumer and business markets in North America, Asia-Pacific, Europe, and internationally. The company is headquartered in West Henrietta, New York.

Want to dig deeper into these stocks?